Mario E. Lacouture on the Psychosocial Impact of Dermatologic AEs

Article

Mario E. Lacouture, MD, discusses the psychosocial impact of dermatologic adverse events from novel therapies in melanoma.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses the psychosocial impact of dermatologic adverse events from novel therapies in melanoma.

This impact has been demonstrated in questionnaires from several studies. Lacouture says he has encountered patients who are not willing to go to work because they do not want to disclose that an acneiform rash is from treatment for melanoma. Lacouture has also seen patients who have been unable to sleep because of rash or pruritus.

Finally, he says that both physicians and nurses need to focus on helping their patients live better as well as longer.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.